| Recruiting | LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients NCT06657326 | Biosensors Europe SA | N/A |
| Completed | Wave Crossover ECP Study for Simplified Therapy NCT06571370 | Pression | N/A |
| Unknown | Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions NCT06249581 | Auxilius Pharma sp.z.o.o. | EARLY_Phase 1 |
| Completed | Yinxingmihuan Oral Solution in Treatment of Chest Pain After PCI NCT06224582 | China National Center for Cardiovascular Diseases | N/A |
| Unknown | The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idi NCT04498962 | Jingqing Hu | N/A |
| Completed | Enhancing Cardiac Rehabilitation Through Behavioral Nudges NCT03834155 | Denver Health and Hospital Authority | N/A |
| Unknown | Myocardial Damage and Music Study NCT03507361 | San Filippo Neri General Hospital | N/A |
| Unknown | Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) NCT03486561 | OBS Pakistan | Phase 4 |
| Unknown | PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy NCT03392948 | Italian Society of Invasive Cardiology | — |
| Terminated | Text Message Intervention to Improve Cardiac Rehab Participation NCT03346278 | University of Washington | N/A |
| Unknown | MYocardial DAmage AND MIcrobiota STUDY NCT02908776 | San Filippo Neri General Hospital | N/A |
| Completed | Mindfulness & Stress Management Study for Cardiac Patients NCT02722213 | University of Minnesota | N/A |
| Active Not Recruiting | REDUCER-I: An Observational Study of the Neovasc Reducer™ System NCT02710435 | Shockwave Medical, Inc. | — |
| Completed | Multi-slice CT Coronary Angiography in Patients With Stable Angina NCT03963609 | Benha University | — |
| Unknown | Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension NCT03063697 | Chong Kun Dang Pharmaceutical | — |
| Completed | Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascul NCT02591758 | Montreal Heart Institute | — |
| Withdrawn | Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries NCT02423265 | East Carolina University | Phase 4 |
| Completed | Vascular Inflammation Imaging Using Somatostatin Receptor Positron Emission Tomography NCT02021188 | University of Cambridge | — |
| Completed | Liraglutide to Improve corONary Haemodynamics During Exercise streSS NCT02315001 | King's College London | Phase 2 |
| Completed | Effects of Ranolazine and Exercise on Daily Physical Activity Trial NCT01948310 | Duke University | Phase 4 |
| Unknown | Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tab NCT01819870 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Coronary Arteriogenetic Heparinized Exercise NCT03350737 | Clinical Centre of Serbia | N/A |
| Completed | A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for NCT01760083 | Euro CTO Club | N/A |
| Completed | Danhong Injection in the Treatment of Chronic Stable Angina NCT01681316 | China Academy of Chinese Medical Sciences | Phase 4 |
| Completed | The Effects of Inorganic Nitrate on Cardiac Muscle in Angina NCT02078921 | University of Aberdeen | Phase 2 |
| Terminated | Allopurinol in Acute Coronary Syndrome NCT01457820 | Stephen McSwiggan | Phase 4 |
| Unknown | Safety of Amiodarone and Ranolazine Together in Patients With Angina NCT01558830 | Cardiovascular Consultants of Nevada | Phase 4 |
| Unknown | Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina. NCT01397994 | Ferozsons Laboratories Ltd. | Phase 4 |
| Completed | A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokin NCT01340248 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule NCT01369472 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Phase IIb Study of STA-2 in Patients With Chronic Stable Angina NCT01239511 | Sinphar Pharmaceutical Co., Ltd | Phase 2 |
| Withdrawn | Capadenoson in Angina Pectoris NCT00518921 | Bayer | Phase 2 |
| Completed | Phase II Study of STA-2 in Patients With Chronic Stable Angina NCT01484912 | Sinphar Pharmaceutical Co., Ltd | Phase 2 |
| Completed | Bioequivalency Study of Amlodipine Tablets Under Fed Conditions NCT00601302 | Roxane Laboratories | N/A |
| Completed | Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions NCT00602017 | Roxane Laboratories | N/A |
| Unknown | A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina NCT00350922 | University of Toronto | Phase 1 |
| Completed | Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes NCT01804439 | University College, London | — |
| Unknown | The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Stu NCT01864031 | University College, London | — |